Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinichi Mashiba

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2005
[Serum amyloid A and LDL complex]Shinichi Mashiba, Kazuo Uchida, Ken Ogasawara
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 19, 2006
Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levelsMasashi Ueda, Yasuyuki Hayase, Shinichi Mashiba
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2002
Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibodyMasashi Ueda, Shinichi Mashiba, Kazuo Uchida
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 5, 2008
Evaluation of adsorption of urine cystatin C to the polymer materials on the microplate by an antigen capture enzyme-linked immunosorbent assayAkiko Gotoh, Kazuo Uchida, Yasuyuki Hamano, et al.
Atherosclerosis|May 12, 2004
A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery diseaseKen Ogasawara, Shinichi Mashiba, Youichiro Wada, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 12, 2008
Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery diseaseKen Ogasawara, Shinichi Mashiba, Hideki Hashimoto, et al.
Journal of Atherosclerosis and Thrombosis|August 21, 2015
High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney DiseaseHirokazu Honda, Tsutomu Hirano, Masashi Ueda, et al.
Atherosclerosis|November 29, 2011
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patientsHirokazu Honda, Masashi Ueda, Shiho Kojima, et al.
Obesity Research & Clinical Practice|December 17, 2013
Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndromeHiroaki Ueno, Yukie Saitoh, Masanari Mizuta, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 18, 2012
Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjectsKazuhiko Kotani, Naoki Sakane, Masashi Ueda, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 5, 2005
[Serum amyloid A and LDL complex]Shinichi Mashiba, Kazuo Uchida, Ken Ogasawara
Clinica Chimica Acta; International Journal of Clinical Chemistry|December 19, 2006
Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levelsMasashi Ueda, Yasuyuki Hayase, Shinichi Mashiba
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 30, 2002
Evaluation of oxidized alpha-1-antitrypsin in blood as an oxidative stress marker using anti-oxidative alpha1-AT monoclonal antibodyMasashi Ueda, Shinichi Mashiba, Kazuo Uchida
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 5, 2008
Evaluation of adsorption of urine cystatin C to the polymer materials on the microplate by an antigen capture enzyme-linked immunosorbent assayAkiko Gotoh, Kazuo Uchida, Yasuyuki Hamano, et al.
Atherosclerosis|May 12, 2004
A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery diseaseKen Ogasawara, Shinichi Mashiba, Youichiro Wada, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 12, 2008
Low-density lipoprotein (LDL), which includes apolipoprotein A-I (apoAI-LDL) as a novel marker of coronary artery diseaseKen Ogasawara, Shinichi Mashiba, Hideki Hashimoto, et al.
Journal of Atherosclerosis and Thrombosis|August 21, 2015
High-Density Lipoprotein Subfractions and Their Oxidized Subfraction Particles in Patients with Chronic Kidney DiseaseHirokazu Honda, Tsutomu Hirano, Masashi Ueda, et al.
Atherosclerosis|November 29, 2011
Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patientsHirokazu Honda, Masashi Ueda, Shiho Kojima, et al.
Obesity Research & Clinical Practice|December 17, 2013
Fenofibrate ameliorates insulin resistance, hypertension and novel oxidative stress markers in patients with metabolic syndromeHiroaki Ueno, Yukie Saitoh, Masanari Mizuta, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 18, 2012
Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjectsKazuhiko Kotani, Naoki Sakane, Masashi Ueda, et al.
Pageof 2